+0.009 (+0.97%)
Range - - -   (-%)
Open -
Previous Close 0.927
Buy Price 2.160
Buy Volume -
Sell Price 2.170
Sell Volume -
Volume 718,710
Value -
Measurement Type Value
EPS (USD) -0.192
Trailing EPS (USD) -0.193
NAV (USD) 0.85
Cash In Hand (USD) 0.02
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 4.74
Price / Cash In Hand 203.535
Issued & Paid-up Shares 162,735,000
Treasury Shares -
Market Cap (M) 414.123
Par Value (USD) n.a.
Beta - 75 Days -
R-Squared - 75 Days(%) -
Beta - 500 Days -
R-Squared - 500 Days(%) -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 04 Oct 2022 03:59.
Data powered by

Upcoming Events

* Stock event date based on US timezone.


Release Date 03 Nov 2022
View All Events


22nd Century Group, Inc. (22nd Century Group) through its subsidiary, 22nd Century Limited, LLC (22nd Century Ltd), which is a plant biotechnology company. The Company focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. Goodrich Tobacco Company, LLC (Goodrich Tobacco) and Hercules Pharmaceuticals, LLC (Hercules Pharmaceuticals) are subsidiaries of 22nd Century Ltd. Goodrich Tobacco is focused on commercial tobacco products and potentially reduced-risk or modified risk tobacco products. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development. In September 2014, the Company acquired NASCO Products, LLC.